PL375044A1 - Nowe diamidy kwasu pirymidyno-4,6-dikarboksylowego do selektywnego hamowania kolagenaz - Google Patents
Nowe diamidy kwasu pirymidyno-4,6-dikarboksylowego do selektywnego hamowania kolagenazInfo
- Publication number
- PL375044A1 PL375044A1 PL03375044A PL37504403A PL375044A1 PL 375044 A1 PL375044 A1 PL 375044A1 PL 03375044 A PL03375044 A PL 03375044A PL 37504403 A PL37504403 A PL 37504403A PL 375044 A1 PL375044 A1 PL 375044A1
- Authority
- PL
- Poland
- Prior art keywords
- dicarboxamides
- collagenases
- selective inhibition
- novel pyrimidine
- pyrimidine
- Prior art date
Links
- 102000029816 Collagenase Human genes 0.000 title 1
- 108060005980 Collagenase Proteins 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- QZMMMOWLQLKASC-UHFFFAOYSA-N pyrimidine-4,6-dicarboxamide Chemical class NC(=O)C1=CC(C(N)=O)=NC=N1 QZMMMOWLQLKASC-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10251019A DE10251019A1 (de) | 2002-11-02 | 2002-11-02 | Neue Pyrimidin-4,6-dicarbonsäurediamide zur selektiven Inhibierung von Kollagenasen |
| DE10254092A DE10254092A1 (de) | 2002-11-20 | 2002-11-20 | Neue Pyrimidin-4,6-dicarbonsäurediamide zur selektiven Inhibierung von Kollagenasen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375044A1 true PL375044A1 (pl) | 2005-11-14 |
Family
ID=32313538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375044A PL375044A1 (pl) | 2002-11-02 | 2003-10-18 | Nowe diamidy kwasu pirymidyno-4,6-dikarboksylowego do selektywnego hamowania kolagenaz |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1560815B1 (pl) |
| JP (1) | JP4564359B2 (pl) |
| KR (1) | KR101050680B1 (pl) |
| AR (1) | AR043058A1 (pl) |
| AT (1) | ATE388941T1 (pl) |
| AU (1) | AU2003301847A1 (pl) |
| BR (1) | BR0315055A (pl) |
| CA (1) | CA2504153C (pl) |
| CO (1) | CO5700759A2 (pl) |
| DE (1) | DE50309381D1 (pl) |
| DK (1) | DK1560815T3 (pl) |
| ES (1) | ES2298621T3 (pl) |
| HR (1) | HRP20050382B1 (pl) |
| MA (1) | MA27412A1 (pl) |
| MX (1) | MXPA05004365A (pl) |
| MY (1) | MY135375A (pl) |
| NO (1) | NO330345B1 (pl) |
| PE (1) | PE20040605A1 (pl) |
| PL (1) | PL375044A1 (pl) |
| PT (1) | PT1560815E (pl) |
| RS (1) | RS20050294A (pl) |
| RU (1) | RU2344129C2 (pl) |
| TW (1) | TWI316512B (pl) |
| WO (1) | WO2004041788A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060173183A1 (en) * | 2004-12-31 | 2006-08-03 | Alantos Pharmaceuticals, Inc., | Multicyclic bis-amide MMP inhibitors |
| JP5463034B2 (ja) * | 2005-05-20 | 2014-04-09 | アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド | ピリミジン若しくはトリアジン縮合二環式メタロプロテアーゼ阻害薬 |
| US20070155738A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| EP2069313A2 (en) * | 2006-06-29 | 2009-06-17 | Alantos Pharmaceuticals Holdings, Inc. | Metalloprotease inhibitors |
| US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
| CL2008001933A1 (es) * | 2007-06-29 | 2009-09-25 | Millennium Pharm Inc | Compuestos derivados de pirimidina, inhibidores de la raf quinasa; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar trastornos proliferativos, cardiacos, neurodegenerativos, inflamatorios, oseos, inmunologicos enfermedad viral, entre otros. |
| AR068509A1 (es) * | 2007-09-19 | 2009-11-18 | Jerini Ag | Antagosnistas del receptor de bradiquinina b1 |
| US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| RU2569678C2 (ru) | 2010-04-22 | 2015-11-27 | Вертекс Фармасьютикалз Инкорпорейтед | Способ получения циклоалкилкарбоксамидо-индольных соединений |
| AR086113A1 (es) | 2011-04-30 | 2013-11-20 | Abbott Lab | Isoxazolinas como agentes terapeuticos |
| PL3925607T5 (pl) | 2014-04-15 | 2026-06-01 | Vertex Pharmaceuticals Incorporated | Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931432A1 (de) * | 1989-09-21 | 1991-04-04 | Hoechst Ag | Pyrimidin-4,6-dicarbonsaeurediamide, verfahren zu deren herstellung sowie verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| DOP2002000332A (es) * | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Inhibidores de piridina de metaloproteinasas de la matriz |
| JP2004518723A (ja) * | 2001-02-14 | 2004-06-24 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | ピリミジンマトリックスメタロプロテイナーゼ阻害剤 |
| DE10160357A1 (de) * | 2001-12-08 | 2003-06-18 | Aventis Pharma Gmbh | Verwendung von Pyridin-2,4-dicarbonsäurediamiden und Pyrimidin-4,6-dicarbonsäurediamiden zur selektiven Inhibierung von Kollagenasen |
-
2003
- 2003-10-18 DE DE50309381T patent/DE50309381D1/de not_active Expired - Lifetime
- 2003-10-18 DK DK03810401T patent/DK1560815T3/da active
- 2003-10-18 EP EP03810401A patent/EP1560815B1/de not_active Expired - Lifetime
- 2003-10-18 MX MXPA05004365A patent/MXPA05004365A/es active IP Right Grant
- 2003-10-18 AT AT03810401T patent/ATE388941T1/de active
- 2003-10-18 AU AU2003301847A patent/AU2003301847A1/en not_active Abandoned
- 2003-10-18 ES ES03810401T patent/ES2298621T3/es not_active Expired - Lifetime
- 2003-10-18 BR BR0315055-0A patent/BR0315055A/pt not_active Application Discontinuation
- 2003-10-18 RS YUP-2005/0294A patent/RS20050294A/sr unknown
- 2003-10-18 HR HRP20050382AA patent/HRP20050382B1/hr not_active IP Right Cessation
- 2003-10-18 WO PCT/EP2003/011515 patent/WO2004041788A1/de not_active Ceased
- 2003-10-18 CA CA2504153A patent/CA2504153C/en not_active Expired - Fee Related
- 2003-10-18 JP JP2004548752A patent/JP4564359B2/ja not_active Expired - Fee Related
- 2003-10-18 PL PL03375044A patent/PL375044A1/pl unknown
- 2003-10-18 PT PT03810401T patent/PT1560815E/pt unknown
- 2003-10-18 KR KR1020057007598A patent/KR101050680B1/ko not_active Expired - Fee Related
- 2003-10-18 RU RU2005116847/04A patent/RU2344129C2/ru not_active IP Right Cessation
- 2003-10-27 PE PE2003001085A patent/PE20040605A1/es not_active Application Discontinuation
- 2003-10-29 TW TW092129976A patent/TWI316512B/zh not_active IP Right Cessation
- 2003-10-30 AR ARP030103974A patent/AR043058A1/es not_active Application Discontinuation
- 2003-10-30 MY MYPI20034144A patent/MY135375A/en unknown
-
2005
- 2005-04-29 CO CO05041024A patent/CO5700759A2/es not_active Application Discontinuation
- 2005-04-29 MA MA28244A patent/MA27412A1/fr unknown
- 2005-05-31 NO NO20052628A patent/NO330345B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101050680B1 (ko) | 2011-07-21 |
| EP1560815A1 (de) | 2005-08-10 |
| ES2298621T3 (es) | 2008-05-16 |
| RS20050294A (sr) | 2007-11-15 |
| EP1560815B1 (de) | 2008-03-12 |
| DE50309381D1 (de) | 2008-04-24 |
| PE20040605A1 (es) | 2004-10-15 |
| HK1083503A1 (zh) | 2006-07-07 |
| CA2504153C (en) | 2012-07-03 |
| AR043058A1 (es) | 2005-07-13 |
| RU2344129C2 (ru) | 2009-01-20 |
| HRP20050382B1 (hr) | 2013-09-30 |
| KR20050067212A (ko) | 2005-06-30 |
| AU2003301847A1 (en) | 2004-06-07 |
| JP4564359B2 (ja) | 2010-10-20 |
| CA2504153A1 (en) | 2004-05-21 |
| RU2005116847A (ru) | 2006-01-20 |
| WO2004041788A1 (de) | 2004-05-21 |
| NO20052628D0 (no) | 2005-05-31 |
| NO330345B1 (no) | 2011-03-28 |
| CO5700759A2 (es) | 2006-11-30 |
| PT1560815E (pt) | 2008-04-07 |
| TW200418808A (en) | 2004-10-01 |
| TWI316512B (en) | 2009-11-01 |
| MXPA05004365A (es) | 2005-07-05 |
| JP2006513158A (ja) | 2006-04-20 |
| MY135375A (en) | 2008-04-30 |
| MA27412A1 (fr) | 2005-06-01 |
| DK1560815T3 (da) | 2008-06-16 |
| NO20052628L (no) | 2005-07-08 |
| ATE388941T1 (de) | 2008-03-15 |
| BR0315055A (pt) | 2005-08-16 |
| HRP20050382A2 (en) | 2006-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL376129A1 (pl) | Pochodne pirydazynonu jako inhibitory GSK-3BETA | |
| ZA200409339B (en) | Novel benzimidazole derivatives. | |
| AU2003216660A1 (en) | N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
| ZA200502210B (en) | Substrates for O6-alkylguanine-DNA alkyltansferase. | |
| IL165046A0 (en) | Pyrimidinone compounds, compositions and methods | |
| AP2005003198A0 (en) | Spiroindolinepiperidine derivatives. | |
| ZA200500170B (en) | Indole-3-sulphur derivatives. | |
| AU2003219410A8 (en) | Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors | |
| ZA200407666B (en) | Pyridinoylpiperidines as 5-HTif agonists. | |
| ZA200307646B (en) | Benzamidine derivative. | |
| SI1555267T1 (sl) | 2,3-DIHIDRO-6-NITROIMIDAZO(2,1-b)OKSAZOLI | |
| ZA200409641B (en) | Novel substituted indoles. | |
| MX267068B (es) | Derivados simetricos de triazina. | |
| AU153030S (en) | Holder for showers | |
| AU2003216677A1 (en) | Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
| PT1560815E (pt) | Novas diamidas do ácido pirimidino-4,6-dicarboxílico para a inibição selectiva de colagenases | |
| MX263097B (es) | Inhibidores de entrada a moleculas pequenas. | |
| IL169318A0 (en) | Pyrimidines, methods for the production thereof, and use thereof | |
| IL164377A0 (en) | Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone | |
| GB0215256D0 (en) | I.t | |
| EG23241A (en) | Beshob. | |
| ZA200306866B (en) | Matches. | |
| ZA200408338B (en) | Heterocyclic compounds. | |
| GB0212492D0 (en) | D.I.Y. workvest | |
| TW545437U (en) | Abstract of the disclosure |